EMIR Anatomy: Difference between revisions
Jump to navigation
Jump to search
Amwelladmin (talk | contribs) No edit summary |
Amwelladmin (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
==={{emirprov|Title II}}: {{emirprov|Clearing, Reporting and Risk Mitigation of OTC Derivatives}}=== | {{a|emir|}}==={{emirprov|Title II}}: {{emirprov|Clearing, Reporting and Risk Mitigation of OTC Derivatives}}=== | ||
:Article {{emirprov|4}} - {{emirprov|Clearing Obligation}} <br> | :Article {{emirprov|4}} - {{emirprov|Clearing Obligation}} <br> | ||
:Article {{emirprov|5}} - {{emirprov|Clearing obligation procedure}} <br> | :Article {{emirprov|5}} - {{emirprov|Clearing obligation procedure}} <br> | ||
| Line 10: | Line 10: | ||
:Article {{emirprov|12}} - {{emirprov|Penalties}} <br> | :Article {{emirprov|12}} - {{emirprov|Penalties}} <br> | ||
:Article {{emirprov|13}} - {{emirprov|Mechanism to avoid duplicative or conflicting rules}} <br> | :Article {{emirprov|13}} - {{emirprov|Mechanism to avoid duplicative or conflicting rules}} <br> | ||
Latest revision as of 10:53, 30 August 2022
|
Title II: Clearing, Reporting and Risk Mitigation of OTC Derivatives
- Article 4 - Clearing Obligation
- Article 5 - Clearing obligation procedure
- Article 6 - Public register
- Article 7 - Access to a CCP
- Article 8 - Access to a trading venue
- Article 9 - Reporting obligation
- Article 10 - Non-financial counterparties
- Article 11 - Risk-mitigation techniques for OTC derivative contracts not cleared by a CCP
- Article 12 - Penalties
- Article 13 - Mechanism to avoid duplicative or conflicting rules